WEKO3
アイテム
{"_buckets": {"deposit": "a936cc21-331c-4c6d-8470-f2d9f4cd07ac"}, "_deposit": {"id": "26229", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "26229"}, "status": "published"}, "_oai": {"id": "oai:nagoya.repo.nii.ac.jp:00026229", "sets": ["501"]}, "author_link": ["78679", "78680", "78681", "78682", "78683", "78684", "78685", "78686", "78687", "78688", "78689", "78690", "78691"], "item_10_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-04", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "113", "bibliographicPageStart": "106", "bibliographicVolumeNumber": "35", "bibliographic_titles": [{"bibliographic_title": "Brain Tumor Pathology", "bibliographic_titleLang": "en"}]}]}, "item_10_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "The IDH-mutant and 1p/19q co-deletion (1p19q codel) provides significant diagnostic and prognostic value in lower-grade gliomas. As ATRX mutation and 1p19q codel are mutually exclusive, ATRX immunohistochemistry (IHC) may substitute for 1p19q codel, but this has not been comprehensively examined. In the current study, we performed ATRX-IHC in 78 gliomas whose ATRX statuses were comprehensively determined by whole exome sequencing. Among the 60 IHC-positive and 18 IHC-negative cases, 86.7 and 77.8% were ATRX-wildtype and ATRX-mutant, respectively. ATRX mutational patterns were not consistent with ATRX-IHC. If our cohort had only used IDH status and IHC-based ATRX expression for diagnosis, 78 tumors would have been subtyped as 48 oligodendroglial tumors, 16 IDH-mutant astrocytic tumors, and 14 IDH-wildtype astrocytic tumors. However, when the 1p19q codel test was performed following ATRX-IHC, 8 of 48 ATRX-IHC-positive tumors were classified as “1p19q non-codel” and 3 of 16 ATRX-IHC-negative tumors were classified as “1p19q codel”; a total of 11 tumors (14%) were incorrectly classified. In summary, we observed dissociation between ATRX-IHC and actual 1p19q codel in 11 of 64 IDH-mutant LGGs. In describing the complex IHC expression of ATRX somatic mutations, our results indicate the need for caution when using ATRX-IHC as a surrogate of 1p19q status.", "subitem_description_language": "en", "subitem_description_type": "Abstract"}]}, "item_10_description_5": {"attribute_name": "内容記述", "attribute_value_mlt": [{"subitem_description": "ファイル公開:2019/04/01 ", "subitem_description_language": "ja", "subitem_description_type": "Other"}]}, "item_10_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Springer", "subitem_publisher_language": "en"}]}, "item_10_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isVersionOf", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1007/s10014-018-0312-5", "subitem_relation_type_select": "DOI"}}]}, "item_10_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "“This is a post-peer-review, pre-copyedit version of an article published in [Brain Tumor Pathology]. The final authenticated version is available online at: http://dx.doi.org/10.1007/s10014-018-0312-5”.", "subitem_rights_language": "en"}]}, "item_10_select_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "author"}]}, "item_10_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1433-7398", "subitem_source_identifier_type": "PISSN"}]}, "item_1615787544753": {"attribute_name": "出版タイプ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_ab4af688f83e57aa", "subitem_version_type": "AM"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Yamamichi, Akane", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78679", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ohka, Fumiharu", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78680", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Aoki, Kosuke", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78681", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Suzuki, Hiromichi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78682", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kato, Akira", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78683", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirano, Masaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78684", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Motomura, Kazuya", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78685", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tanahashi, Kuniaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78686", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Chalise, Lushun", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78687", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Maeda, Sachi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78688", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Wakabayashi, Toshihiko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78689", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kato, Yukinari", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78690", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Natsume, Atsushi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "78691", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-04-01"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "BTPA-S-18-00028-3.pdf", "filesize": [{"value": "2.7 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_note", "mimetype": "application/pdf", "size": 2700000.0, "url": {"label": "BTPA-S-18-00028-3", "objectType": "fulltext", "url": "https://nagoya.repo.nii.ac.jp/record/26229/files/BTPA-S-18-00028-3.pdf"}, "version_id": "39c47c18-e706-4438-ac5f-5f3f957adeac"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion", "subitem_title_language": "en"}]}, "item_type_id": "10", "owner": "1", "path": ["501"], "permalink_uri": "http://hdl.handle.net/2237/00028433", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2018-08-07"}, "publish_date": "2018-08-07", "publish_status": "0", "recid": "26229", "relation": {}, "relation_version_is_last": true, "title": ["Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion"], "weko_shared_id": -1}
Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion
http://hdl.handle.net/2237/00028433
http://hdl.handle.net/2237/00028433e11ec53c-64b3-4a3c-a414-ed1af5c46b4d
名前 / ファイル | ライセンス | アクション |
---|---|---|
BTPA-S-18-00028-3 (2.7 MB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-08-07 | |||||
タイトル | ||||||
タイトル | Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion | |||||
言語 | en | |||||
著者 |
Yamamichi, Akane
× Yamamichi, Akane× Ohka, Fumiharu× Aoki, Kosuke× Suzuki, Hiromichi× Kato, Akira× Hirano, Masaki× Motomura, Kazuya× Tanahashi, Kuniaki× Chalise, Lushun× Maeda, Sachi× Wakabayashi, Toshihiko× Kato, Yukinari× Natsume, Atsushi |
|||||
アクセス権 | ||||||
アクセス権 | open access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||
権利 | ||||||
言語 | en | |||||
権利情報 | “This is a post-peer-review, pre-copyedit version of an article published in [Brain Tumor Pathology]. The final authenticated version is available online at: http://dx.doi.org/10.1007/s10014-018-0312-5”. | |||||
抄録 | ||||||
内容記述 | The IDH-mutant and 1p/19q co-deletion (1p19q codel) provides significant diagnostic and prognostic value in lower-grade gliomas. As ATRX mutation and 1p19q codel are mutually exclusive, ATRX immunohistochemistry (IHC) may substitute for 1p19q codel, but this has not been comprehensively examined. In the current study, we performed ATRX-IHC in 78 gliomas whose ATRX statuses were comprehensively determined by whole exome sequencing. Among the 60 IHC-positive and 18 IHC-negative cases, 86.7 and 77.8% were ATRX-wildtype and ATRX-mutant, respectively. ATRX mutational patterns were not consistent with ATRX-IHC. If our cohort had only used IDH status and IHC-based ATRX expression for diagnosis, 78 tumors would have been subtyped as 48 oligodendroglial tumors, 16 IDH-mutant astrocytic tumors, and 14 IDH-wildtype astrocytic tumors. However, when the 1p19q codel test was performed following ATRX-IHC, 8 of 48 ATRX-IHC-positive tumors were classified as “1p19q non-codel” and 3 of 16 ATRX-IHC-negative tumors were classified as “1p19q codel”; a total of 11 tumors (14%) were incorrectly classified. In summary, we observed dissociation between ATRX-IHC and actual 1p19q codel in 11 of 64 IDH-mutant LGGs. In describing the complex IHC expression of ATRX somatic mutations, our results indicate the need for caution when using ATRX-IHC as a surrogate of 1p19q status. | |||||
言語 | en | |||||
内容記述タイプ | Abstract | |||||
内容記述 | ||||||
内容記述 | ファイル公開:2019/04/01 | |||||
言語 | ja | |||||
内容記述タイプ | Other | |||||
出版者 | ||||||
言語 | en | |||||
出版者 | Springer | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプresource | http://purl.org/coar/resource_type/c_6501 | |||||
タイプ | journal article | |||||
出版タイプ | ||||||
出版タイプ | AM | |||||
出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
DOI | ||||||
関連タイプ | isVersionOf | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.1007/s10014-018-0312-5 | |||||
ISSN | ||||||
収録物識別子タイプ | PISSN | |||||
収録物識別子 | 1433-7398 | |||||
書誌情報 |
en : Brain Tumor Pathology 巻 35, 号 2, p. 106-113, 発行日 2018-04 |
|||||
著者版フラグ | ||||||
値 | author |